Voyager Therapeutics Inc VT6.BE
€3.69 €0.08 (2.22%) 1D
Last Updated: Dec 17, 12:00 AM·BE
Pricing for DE stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
Pricing
Company
About Musaffa
Investors
Build with us
Is Voyager Therapeutics Inc Stock Halal?
Shariah Compliance Analysis of VT6.BE Stock
Germany Health Care Micro Cap No. As of September 2026, Voyager Therapeutics Inc (VT6.BE) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Voyager Therapeutics Inc does not pass Musaffa's business and financial screening criteria.
Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. The company is headquartered in Lexington, Massachusetts and currently employs 172 full-time employees. The company went IPO on 2015-11-11. The Company’s pipeline includes programs for Alzheimer’s disease, Friedreich’s ataxia, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and multiple other diseases of the central nervous system. Many of its programs are derived from its Tropism Redirection of AAV by Cell-type-specific Expression of RNA (TRACER) adeno-associated virus (AAV) capsid discovery platform, which is used to generate capsids and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous dosing. Its pipeline of programs includes Anti-Tau Antibody (VY7523), Tau Silencing Gene Therapy (VY1706), SOD1 Silencing Gene Therapy Program, Vectorized Anti-Amyloid Antibody Early Research Program, Friedreich’s Ataxia Program: VY-FXN01, GBA1 Gene Replacement Program, HD Program and others.
VT6.BE Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, Voyager Therapeutics Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Voyager Therapeutics Inc (VT6.BE) Chart
Financial Metrics & Statements of Voyager Therapeutics Inc (VT6.BE)
FAQ's for Voyager Therapeutics Inc (VT6.BE)
- As of September 2026, Voyager Therapeutics Inc VT6.BE is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Voyager Therapeutics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Voyager Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Voyager Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Voyager Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Voyager Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Voyager Therapeutics Inc (VT6.BE)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
